Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Murphy

Showing results (571-580 of 751) with videos related to

Pageof 76
Sort By:
CA: a Cancer Journal for Clinicians|March 1, 1994
Clinical highlights from the National Cancer Data Base: 1994G D Steele, R T Osteen, D P Winchester, et al.
The Journal of Urology|February 1, 1975
Ectopic production of erythropoietin in Wilms tumor patients in relation to clinical stage and disease activityG P Murphy, E A Mirand, L F Sinks, et al.
New York State Journal of Medicine|June 1, 1978
Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrowR Catane, S Madajewicz, Z L Wajsman, et al.
Urology|December 1, 1996
Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigenT O Morgan, D G McLeod, E S Leifer, et al.
The Journal of Urology|January 1, 1982
Treatment of testicular tumors arising in patients with previous inguinal and/or scrotal surgeryV J Lanteri, M Choudhury, J E Pontes, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Immunochemical characterization of prostatic acid phosphatase with monoclonal antibodiesC L Lee, C Y Li, Y H Jou, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Prostate-specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancerC S Killian, F P Vargas, N H Slack, et al.
Cancer|December 24, 1997
The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM stagingI D Fleming, J L Phillips, H R Menck, et al.
Cancer Research|March 8, 2000
Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trialP A Lodge, L A Jones, R A Bader, et al.
Cancer|December 11, 1999
American Joint Committee on Cancer prognostic factors consensus conferenceJ W Yarbro, D L Page, L P Fielding, et al.
Pageof 76

Showing results (571-580 of 751) with videos related to

Sort By:
Pageof 76
CA: a Cancer Journal for Clinicians|March 1, 1994
Clinical highlights from the National Cancer Data Base: 1994G D Steele, R T Osteen, D P Winchester, et al.
The Journal of Urology|February 1, 1975
Ectopic production of erythropoietin in Wilms tumor patients in relation to clinical stage and disease activityG P Murphy, E A Mirand, L F Sinks, et al.
New York State Journal of Medicine|June 1, 1978
Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrowR Catane, S Madajewicz, Z L Wajsman, et al.
Urology|December 1, 1996
Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigenT O Morgan, D G McLeod, E S Leifer, et al.
The Journal of Urology|January 1, 1982
Treatment of testicular tumors arising in patients with previous inguinal and/or scrotal surgeryV J Lanteri, M Choudhury, J E Pontes, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Immunochemical characterization of prostatic acid phosphatase with monoclonal antibodiesC L Lee, C Y Li, Y H Jou, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Prostate-specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancerC S Killian, F P Vargas, N H Slack, et al.
Cancer|December 24, 1997
The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM stagingI D Fleming, J L Phillips, H R Menck, et al.
Cancer Research|March 8, 2000
Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trialP A Lodge, L A Jones, R A Bader, et al.
Cancer|December 11, 1999
American Joint Committee on Cancer prognostic factors consensus conferenceJ W Yarbro, D L Page, L P Fielding, et al.
Pageof 76